Kristina Sjöblom Nygren

Kristina Sjöblom Nygren is an Independent Director at Infant Bacterial Therapeutics AB since 2018.
She is also currently serving as the Chief Medical Officer at Egetis Therapeutics AB since 2021.
Previously, she worked as a Group Director-Development at Astrazeneca AG from 2007 to 2008 and as a Medical Director at Pfizer AG from 1998 to 2003.
From 2017 to 2020, she held the position of Chief Medical Officer, EVP & Head-Development at Santhera Pharmaceuticals Holding AG.
Additionally, she has experience as the Vice President & Head-Clinical Development at Swedish Orphan Biovitrum AB.
Dr. Sjöblom Nygren obtained her doctorate degree from Karolinska Institutet.